| 2024年中报 | 2023年年报 | 2023年中报 | 2022年年报 | 2022年中报 | |
|---|---|---|---|---|---|
| 营业收入(元) | |||||
| 妇科及计生用药(元) | 418,424,516.42 | 838,404,986.58 | 436,111,097.71 | 910,697,094.35 | 417,265,025.15 |
| 麻醉及肌松用药(元) | 129,573,898.43 | 175,412,173.56 | 89,639,378.40 | 580,956,439.14 | 354,930,425.57 |
| 皮质激素(元) | 1,233,732,668.28 | 2,441,347,916.24 | 1,199,293,204.40 | 2,186,394,160.07 | 1,052,652,513.88 |
| 其他(元) | 356,116,526.70 | 668,253,507.81 | 393,076,559.41 | 701,778,002.32 | 390,449,734.76 |
| 营业成本(元) | |||||
| 妇科及计生用药(元) | 155,209,244.44 | 297,747,461.05 | 160,144,834.78 | 290,512,528.16 | 133,579,585.43 |
| 麻醉及肌松用药(元) | 33,666,796.24 | 78,024,532.96 | 39,843,187.34 | 86,175,496.39 | 83,936,393.07 |
| 皮质激素(元) | 520,355,637.91 | 1,126,641,753.28 | 557,152,973.16 | 1,006,325,311.54 | 427,721,469.37 |
| 其他(元) | 256,166,164.50 | 440,710,581.68 | 266,237,603.15 | 226,490,810.83 | 281,431,103.85 |
| 毛利(元) | |||||
| 妇科及计生用药(元) | 263,215,271.98 | 540,657,525.53 | 275,966,262.93 | 620,184,566.19 | 283,685,439.72 |
| 麻醉及肌松用药(元) | 95,907,102.19 | 97,387,640.60 | 49,796,191.06 | 494,780,942.75 | 270,994,032.50 |
| 皮质激素(元) | 713,377,030.37 | 1,314,706,162.96 | 642,140,231.24 | 1,180,068,848.53 | 624,931,044.51 |
| 其他(元) | 99,950,362.20 | 227,542,926.13 | 126,838,956.26 | 475,287,191.49 | 109,018,630.91 |
| 毛利率(%) | |||||
| 妇科及计生用药(%) | 62.91 | 64.49 | 63.28 | 68.10 | 67.99 |
| 麻醉及肌松用药(%) | 74.02 | 55.52 | 55.55 | 85.17 | 76.35 |
| 皮质激素(%) | 57.82 | 53.85 | 53.54 | 53.97 | 59.37 |
| 其他(%) | 28.07 | 34.05 | 32.27 | 67.73 | 27.92 |
| 收入构成(%) | |||||
| 妇科及计生用药(%) | 19.57 | 20.33 | 20.59 | 20.79 | 18.84 |
| 麻醉及肌松用药(%) | 6.06 | 4.25 | 4.23 | 13.26 | 16.02 |
| 皮质激素(%) | 57.71 | 59.21 | 56.62 | 49.92 | 47.52 |
| 其他(%) | 16.66 | 16.21 | 18.56 | 16.02 | 17.63 |
| 毛利构成(%) | |||||
| 妇科及计生用药(%) | 22.45 | 24.80 | 25.21 | 22.39 | 22.01 |
| 麻醉及肌松用药(%) | 8.18 | 4.47 | 4.55 | 17.86 | 21.03 |
| 皮质激素(%) | 60.84 | 60.30 | 58.66 | 42.60 | 48.50 |
| 其他(%) | 8.52 | 10.44 | 11.59 | 17.16 | 8.46 |